ArticleslgStudy

chemistry

VCU-1012

VCU-1012 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand VCU-1012 rather than just read about it. In short: VCU-1012, also known as 1-quinazolin-2-ylpiperazine or as 3-azaquipazine, is a psychedelic drug of the arylpiperazine family related to quipazine (1-(2-quinolinyl)piperazine). It is a serotonin 5-HT2A receptor agonist and produces psychedelic-like effects in rodents similarly to quipazine, but lacks quipazine's serotonin 5-HT3 receptor agonism and associated gastrointestinal adverse effects like nausea and vomiting.

VCU-1012 — main illustration
VCU-1012 — illustration

Key takeaways

  • VCU-1012 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect VCU-1012 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of VCU-1012 from memory before moving on to harder problems.

Reference excerpt

VCU-1012, also known as 1-quinazolin-2-ylpiperazine or as 3-azaquipazine, is a psychedelic drug of the arylpiperazine family related to quipazine (1-(2-quinolinyl)piperazine). It is a serotonin 5-HT2A receptor agonist and produces psychedelic-like effects in rodents similarly to quipazine, but lacks quipazine's serotonin 5-HT3 receptor agonism and associated gastrointestinal adverse effects like nausea and vomiting. The drug represents a novel structural class of psychedelics distinct from existing scaffolds.

Interactions

Pharmacology

Pharmacodynamics VCU-1012 is an agonist of the serotonin 5-HT2A receptor. It shows about half the affinity of quipazine for the serotonin 5-HT2A receptor (Ki = 986 nM and 1,777 nM, respectively). The drug is a partial agonist of the serotonin 5-HT2A receptor, with about half the activational potency of quipazine (VCU-1012, EC50Tooltip half-maximal effective concentration = 1,550 nM; EmaxTooltip maximal efficacy = 46%; quipazine, EC50Tooltip half-maximal effective concentration = 240 nM; EmaxTooltip maximal efficacy = 56%). In addition to the serotonin 5-HT2A receptor, VCU-1012 shows high affinity for the serotonin 5-HT2B receptor (Ki = 24–31 nM) and for the 5-HT3 receptor (Ki = 8.3–14 nM). It also shows affinity for a variety of other receptors and for monoamine transporters, including the norepinephrine transporter (NET) and the serotonin transporter (SERT). Although VCU-1012 binds to the serotonin 5-HT3 receptor, unlike quipazine, it does not act as an agonist of this receptor. Relatedly, VCU-1012 did not produce the gastrointestinal effects of quipazine in rodents and would be expected to lack associated side effects like nausea and vomiting in humans. It is unknown whether VCU-1012 acts pharmacologically as a serotonin 5-HT3 receptor antagonist. It is also unclear whether it acts as an agonist or antagonist at the serotonin 5-HT2B receptor. The drug dose-dependently and robustly induces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. This is fully blocked by the serotonin 5-HT2A receptor antagonist volinanserin. VCU-1012 produces prolonged antidepressant-like effects in rodents. It also produces anxiolytic-like effects. The drug produces psychoplastogenic effects as well, which were mediated by serotonin 5-HT2A receptor activation.

Chemistry VCU-1012, along with quipazine, represents a novel structural class of psychedelics distinct from tryptamines, phenethylamines, and lysergamides.

Synthesis The chemical synthesis of VCU-1012 has been described.

Analogues Other novel psychedelic analogues of quipazine besides VCU-1012 have also been described. Notable psychedelic analogues of VCU-1012 besides quipazine include 2-naphthylpiperazine (2-NP) and VCU-1021 (3-methoxyquipazine).

History VCU-1012 was first described in the scientific literature by Jessica Maltman and Richard Glennon and colleagues at Virginia Commonwealth University (VCU) in 2024. It may have therapeutic potential and possible medical applications.

See also Arylpiperazine Quipazine List of miscellaneous serotonin 5-HT2A receptor agonists

References

Illustrations

VCU-1012 illustration
VCU-1012 illustration

Worked examples

Example 1 — a first encounter with VCU-1012

Start with the simplest possible case. Write down what VCU-1012 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to VCU-1012 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about VCU-1012 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of VCU-1012

In research
VCU-1012 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses VCU-1012 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
VCU-1012 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT2A agonists, Drugs not assigned an ATC code, Drugs with undisclosed chemical structures, so understanding it makes those chapters shorter.
In everyday life
Look for VCU-1012 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study VCU-1012 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what VCU-1012 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain VCU-1012 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is VCU-1012 in simple terms?

VCU-1012, also known as 1-quinazolin-2-ylpiperazine or as 3-azaquipazine, is a psychedelic drug of the arylpiperazine family related to quipazine (1-(2-quinolinyl)piperazine). It is a serotonin 5-HT2A receptor agonist and produces psychedelic-like effects in rodents similarly to quipazine, but lack…

Why does VCU-1012 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study VCU-1012?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on VCU-1012.

Tags

  • 5-HT2A agonists
  • Drugs not assigned an ATC code
  • Drugs with undisclosed chemical structures
  • Psychedelic arylpiperazines

Keep exploring